Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nant Health, LLC | 100,000 | reported | 09 Jun 2022 | tx 7+750,688 |
| Dipexium Pharmaceuticals, LLC | 40,000 | reported | 18 Nov 2020 | tx 5+90,677 |
| RESPONSE GENETICS INC | 33,750 | reported | 10 Jul 2014 | tx 11+170,812 |
| AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ | 10,000 | reported | 01 Aug 2006 | tx 1+10,000 |
| REPLIDYNE INC | 8,156 | reported | 08 May 2008 | tx 2+16,312 |
| Ryerson Holding Corp | 4,187 | reported | 01 Jan 2026 | tx 11+4,187 |
| Adams Respiratory Therapeutics, Inc. | 0 | reported | 29 Jan 2008 | tx 16+10,796−19,184 |
| Abraxis Biosciences, Inc. | 0 | reported | 15 Oct 2010 | tx 16+36,439−36,439 |
| MYOGEN INC | 0 | reported | 14 Nov 2006 | tx 7+17,500−47,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | GRANT_AWARD | Ryerson Holding Corp | 347 | 0.00 USD | |
| 30 Sept 2025 | GRANT_AWARD | Ryerson Holding Corp | 382 | 0.00 USD | |
| 30 Jun 2025 | GRANT_AWARD | Ryerson Holding Corp | 405 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Ryerson Holding Corp | 381 | 0.00 USD | |
| 31 Dec 2024 | GRANT_AWARD | Ryerson Holding Corp | 472 | 0.00 USD | |
| 01 Oct 2024 | GRANT_AWARD | Ryerson Holding Corp | 439 | 0.00 USD | |
| 01 Jul 2024 | GRANT_AWARD | Ryerson Holding Corp | 448 | 0.00 USD | |
| 01 Apr 2024 | GRANT_AWARD | Ryerson Holding Corp | 261 | 0.00 USD | |
| 12 Jan 2024 | GRANT_AWARD | Ryerson Holding Corp | 252 | 0.00 USD | |
| 02 Oct 2023 | GRANT_AWARD | Ryerson Holding Corp | 300 | 0.00 USD | |
| 09 Jun 2022 | GRANT_AWARD | Nant Health, LLC | 100,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Nant Health, LLC | 100,000 | 0.00 USD | deriv |
| 18 Nov 2020 | GRANT_AWARD | Dipexium Pharmaceuticals, LLC | 40,000 | 0.00 USD | deriv |
| 21 May 2020 | GRANT_AWARD | Nant Health, LLC | 100,000 | 0.00 USD | deriv |
| 20 Mar 2020 | GRANT_AWARD | Dipexium Pharmaceuticals, LLC | 20,000 | 0.00 USD | deriv |
| 13 Jun 2019 | GRANT_AWARD | Nant Health, LLC | 301,908 | 0.00 USD | deriv |
| 14 Mar 2019 | GRANT_AWARD | Dipexium Pharmaceuticals, LLC | 20,000 | 0.00 USD | deriv |
| 06 Sept 2018 | GRANT_AWARD | Nant Health, LLC | 45,002 | 0.00 USD | |
| 06 Sept 2018 | GRANT_AWARD | Nant Health, LLC | 52,910 | 0.00 USD | |
| 06 Nov 2017 | GRANT_AWARD | Nant Health, LLC | 50,868 | 0.00 USD | |
| 19 Apr 2017 | GRANT_AWARD | Dipexium Pharmaceuticals, LLC | 1,675 | — | |
| 19 Apr 2017 | GRANT_AWARD | Dipexium Pharmaceuticals, LLC | 9,002 | 0.00 USD | deriv |
| 13 Aug 2014 | PURCHASE | Ryerson Holding Corp | 500 | 11.00 USD | first after silence |
| 10 Jul 2014 | GRANT_AWARD | RESPONSE GENETICS INC | 33,750 | 0.00 USD | deriv |
| 20 Nov 2013 | GRANT_AWARD | RESPONSE GENETICS INC | 33,750 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Aug 2014.